Meta-analysis of 28 studies (71,400 patients with myelodysplastic syndrome): cardiovascular disease was 6.2 times more common than in the general population, heart failure prevalence 10.4–18.6%, and multimorbidity 79.1% vs 63.4% (p<.0001).
Meta-analysisn = 71,400
Liapis et al. Excess risk for cardiovascular and noncardiovascular comorbidities and multimorbidity among patients with myelodysplastic syndrome: A systematic review and meta-analysis